01 172JANSSEN PHARMS
01 210617668*PED
02 307943582
03 107943788
04 308222219
05 308513202
06 88785403
07 1810617668
08 411576894
09 107943582*PED
10 107943788*PED
11 108222219*PED
12 108513202*PED
01 70Y
02 102Blank
01 100Y
02 72Blank
01 82024-07-30
02 302025-04-11
03 102025-10-11
04 102027-07-14
05 302027-12-03
06 102028-01-14
07 102028-06-03
08 302029-02-26
09 102029-08-26
10 42030-07-06
11 182031-05-11
12 22031-11-11
Patent Expiration Date : 2029-02-26
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 7943582
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204353
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2029-02-26
Patent Expiration Date : 2027-12-03
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8513202
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204353
Patent Use Code : U-2441
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-12-03
Patent Expiration Date : 2027-12-03
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8513202
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204353
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-12-03
Patent Expiration Date : 2025-04-11
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8222219
Drug Substance Claim :
Drug Product Claim :
Application Number : 204353
Patent Use Code : U-2441
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-04-11
Patent Expiration Date : 2029-02-26
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 7943582
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204353
Patent Use Code : U-2441
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-02-26
Patent Expiration Date : 2025-04-11
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8222219
Drug Substance Claim :
Drug Product Claim :
Application Number : 204353
Patent Use Code : U-2441
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-04-11
Patent Expiration Date : 2025-04-11
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8222219
Drug Substance Claim :
Drug Product Claim :
Application Number : 204353
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-04-11
Patent Expiration Date : 2027-12-03
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8513202
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204353
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-12-03
Patent Expiration Date : 2029-02-26
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 7943582
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204353
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2029-02-26
Patent Expiration Date : 2025-04-11
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8222219
Drug Substance Claim :
Drug Product Claim :
Application Number : 204353
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-04-11
